ImportRefusal LogoImportRefusal

Angel Cosmetics

⚠️ High Risk

FEI: 3008325077 • Kinshasa • DEMOCRATIC REPUBLIC OF THE CONGO

FEI

FEI Number

3008325077

📍

Location

Kinshasa

🏢

Address

Rue Limitee 17e, , Kinshasa, , Democratic Republic of the Congo

High Risk

FDA Import Risk Assessment

55.8
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

22
Total Refusals
8
Unique Violations
1/9/2024
Latest Refusal
7/26/2010
Earliest Refusal

Score Breakdown

Violation Severity
67.7×40%
Refusal Volume
50.4×30%
Recency
59.9×20%
Frequency
16.3×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

7515×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

2236×

FALSE

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose labeling appears to be false or misleading.

1185×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

3354×

LACKS N/C

The article is in package form and appears to not have a label containing an accurate statement of the quantity of the contents in terms of weight, measure or numerical count and no variations or exemptions have been prescribed by regs.

22802×

DIRSEXMPT

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a drug within the meaning of Section 201(g) and it lacks adequate directions for use.

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

3361×

INCONSPICU

Information required by the Act to be on the label or labeling does not appear to be conspicuous enough as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.

4731×

LABELING

The article appears in violation of FPLA because of its placement, form and/or contents statement.

Refusal History

DateProductViolationsDivision
1/9/2024
53LC06MOISTURIZING (SKIN CARE PREPARATIONS)
75UNAPPROVED
Division of Northeast Imports (DNEI)
11/7/2023
63VCJ02HYDROQUINONE (DEPIGMENTOR)
75UNAPPROVED
Division of Northeast Imports (DNEI)
8/10/2023
53LC99OTHER SKIN CARE PREPARATIONS, N.E.C.
2280DIRSEXMPT
Division of Northern Border Imports (DNBI)
8/10/2023
53LC99OTHER SKIN CARE PREPARATIONS, N.E.C.
2280DIRSEXMPT
Division of Northern Border Imports (DNBI)
4/19/2019
63VBL02HYDROQUINONE (DEPIGMENTOR)
223FALSE
473LABELING
75UNAPPROVED
Division of Northern Border Imports (DNBI)
4/19/2019
63VBL02HYDROQUINONE (DEPIGMENTOR)
223FALSE
75UNAPPROVED
Division of Northern Border Imports (DNBI)
4/19/2019
63VBL02HYDROQUINONE (DEPIGMENTOR)
223FALSE
75UNAPPROVED
Division of Northern Border Imports (DNBI)
4/19/2019
63VBL02HYDROQUINONE (DEPIGMENTOR)
223FALSE
75UNAPPROVED
Division of Northern Border Imports (DNBI)
4/19/2019
63VBL02HYDROQUINONE (DEPIGMENTOR)
223FALSE
75UNAPPROVED
Division of Northern Border Imports (DNBI)
4/19/2019
63VBL02HYDROQUINONE (DEPIGMENTOR)
223FALSE
75UNAPPROVED
Division of Northern Border Imports (DNBI)
2/27/2014
63VBL02HYDROQUINONE (DEPIGMENTOR)
118NOT LISTED
3280FRNMFGREG
Cincinnati District Office (CIN-DO)
1/18/2013
63VBJ02HYDROQUINONE (DEPIGMENTOR)
75UNAPPROVED
New England District Office (NWE-DO)
1/18/2013
63VBJ02HYDROQUINONE (DEPIGMENTOR)
75UNAPPROVED
New England District Office (NWE-DO)
1/18/2013
63VBJ02HYDROQUINONE (DEPIGMENTOR)
75UNAPPROVED
New England District Office (NWE-DO)
1/18/2013
63VBJ02HYDROQUINONE (DEPIGMENTOR)
75UNAPPROVED
New England District Office (NWE-DO)
9/14/2012
63VBJ02HYDROQUINONE (DEPIGMENTOR)
75UNAPPROVED
New England District Office (NWE-DO)
5/18/2012
66YBY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
118NOT LISTED
335LACKS N/C
Minneapolis District Office (MIN-DO)
5/18/2012
66YBY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
118NOT LISTED
335LACKS N/C
Minneapolis District Office (MIN-DO)
5/18/2012
66YBY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
118NOT LISTED
335LACKS N/C
Minneapolis District Office (MIN-DO)
5/18/2012
66YBY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
118NOT LISTED
335LACKS N/C
Minneapolis District Office (MIN-DO)
10/19/2010
63VDY02HYDROQUINONE (DEPIGMENTOR)
336INCONSPICU
75UNAPPROVED
Detroit District Office (DET-DO)
7/26/2010
63VBY02HYDROQUINONE (DEPIGMENTOR)
75UNAPPROVED
Southwest Import District Office (SWI-DO)

Frequently Asked Questions

What is Angel Cosmetics's FDA import refusal history?

Angel Cosmetics (FEI: 3008325077) has 22 FDA import refusal record(s) in our database, spanning from 7/26/2010 to 1/9/2024.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Angel Cosmetics's FEI number is 3008325077.

What types of violations has Angel Cosmetics received?

Angel Cosmetics has been cited for 8 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Angel Cosmetics come from?

All FDA import refusal data for Angel Cosmetics is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.